Sandoz Wants Rapaflo Infringement Suit Trimmed
Sandoz Inc. on Monday asked a Delaware federal judge to trim a suit accusing its planned generic version of Actavis Inc.'s enlarged-prostate drug Rapaflo of infringing a patent covering the drug,...To view the full article, register now.
Already a subscriber? Click here to view full article